Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge

Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion

(2013) Robert Tarran et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

ABCA3 Transporter Deficiency

(2013) Don Hayes et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Starvation, Together with the SOS Response, Mediates High Biofilm-Specific Tolerance to the Fluoroquinolone Ofloxacin

(2013) Steve P. Bernier et al.   PLoS Genetics

Long-term macrolide treatment for chronic respiratory disease

(2012) Paolo Spagnolo et al.   EUROPEAN RESPIRATORY JOURNAL

In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients

(2012) Ana Fernández-Olmos et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Absence of the cystic fibrosis transmembrane regulator (Cftr ) from myeloid-derived cells slows resolution of inflammation and infection

(2012) T. L. Bonfield et al.   JOURNAL OF LEUKOCYTE BIOLOGY

N′-Substituted-2′-O,3′-N-carbonimidoyl Bridged Macrolides: Novel Anti-inflammatory Macrolides without Antimicrobial Activity

(2012) Martina Bosnar et al.   JOURNAL OF MEDICINAL CHEMISTRY

Azithromycin and the Risk of Cardiovascular Death

(2012) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis

(2011) Andrea Mencarelli et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells

(2011) Vinciane Saint-Criq et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review

(2011) Yun Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Azithromycin for Prevention of Exacerbations of COPD

(2011) Richard K. Albert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia

(2010) Martina Bosnar et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosaA Randomized Controlled Trial

(2010) Lisa Saiman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Role of Azithromycin in Patients with Cystic Fibrosis

(2010) Abdullah A. Yousef et al.   Paediatric Respiratory Reviews

Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis

(2009) Magali Meyer et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB Mutants

(2009) X. Mulet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice

(2009) Ximena Gavilanes et al.   Journal of Cystic Fibrosis

Azithromycin and Clarithromycin Inhibit Lipopolysaccharide-Induced Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1 

(2009) M. Bosnar et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Enhanced Innate Immune Responsiveness to Pulmonary Cryptococcus neoformans Infection Is Associated with Resistance to Progressive Infection

(2008) L. Guillot et al.   INFECTION AND IMMUNITY